ZhangCZouYLMaJDangXQWangKZ. Apoptosis associated with wnt/beta-catenin pathway leads to steroid-induced avascular necrosis of femoral head. BMC Musculoskelet Disord2015; 16: 132–132.
2.
ErkenHYOfluogluOAktasMTopalCYildizM. Effect of pentoxifylline on histopathological changes in steroid-induced osteonecrosis of femoral head: experimental study in chicken. Int Orthop2012; 36: 1523–8.
3.
KaushikAPDasACuiQ. Osteonecrosis of the femoral head: an update in year 2012. World J Orthop2012; 3: 49–57.
4.
LeeYJLeeJSKangEHLeeYKKimSYSongYWKooKH. Vascular endothelial growth factor polymorphisms in patients with steroid-induced femoral head osteonecrosis. J Orthop Res2012; 30: 21–7.
5.
NeyJTFehmTJuhasz-BoessISolomayerEF. Rank, rankl and opg expression in breast cancer - influence on osseous metastasis. Geburtshilfe Frauenheilkd2012; 72: 385–91.
6.
SongHMWeiYCLiNWuBXieNZhangKMWangSZWangHM. Effects of wenyangbushen formula on the expression of vegf, opg, rank and rankl in rabbits with steroid-induced femoral head avascular necrosis. Mol Med Rep2015; 12: 8155–61.
7.
PapaioannouGMirzamohammadiFKobayashiT. Micrornas involved in bone formation. Cell Mol Life Sci2014; 71: 4747–61.
8.
HuYPuQCuiBLinJ. Microrna-34a inhibits tumor invasion and metastasis in gastric cancer by targeting tgif2. Int J Clin Exp Pathol2015; 8: 8921–8.
9.
KrzeszinskiJYWeiWHuynhHJinZWangXChangTCXieXJHeLMangalaLSLopez-BeresteinGSoodAKMendellJTWanY. Mir-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and tgif2. Nature2014; 512: 431–5.
10.
WeiJShiYZhengLZhouBInoseHWangJGuoXEGrosschedlRKarsentyG. Mir-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting satb2. J Cell Biol2012; 197: 509–21.
11.
HadjidakisDJAndroulakisII. Bone remodeling. Ann N Y Acad Sci2006; 1092: 385–96.
12.
RoshandelDHollidayKLPyeSRBoonenSBorghsHVanderschuerenDHuhtaniemiITAdamsJEWardKABartfaiGCasanuevaFFinnJDFortiGGiwercmanAHanTSKulaKLeanMEPendletonNPunabMSilmanAJWuFCThomsonWO'NeillTWGroupES. Genetic variation in the rankl/rank/opg signaling pathway is associated with bone turnover and bone mineral density in men. J Bone Miner Res2010; 25: 1830–8.
13.
LopesHBFerrazEPAlmeidaALFlorioPGimenesRRosaALBelotiMM. Participation of microrna-34a and rankl on bone repair induced by poly(vinylidene-trifluoroethylene)/barium titanate membrane. J Biomater Sci Polym Ed2016; 27: 1369–79.
14.
MartinTJSimsNA. Rankl/opg; critical role in bone physiology. Rev Endocr Metab Disord2015; 16: 131–9.
15.
TanakaS. Signaling axis in osteoclast biology and therapeutic targeting in the rankl/rank/opg system. Am J Nephrol2007; 27: 466–78.
16.
ChenYCSosnoskiDMMastroAM. Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res2010; 12: 215–215.
17.
WangYWangCMJiangZZYuXJFanCGXuFFZhangQLiLILiRFSunWSZhangZHLiuYG. Microrna-34c targets tgfb-induced factor homeobox 2, represses cell proliferation and induces apoptosis in hepatitis b virus-related hepatocellular carcinoma. Oncol Lett2015; 10: 3095–102.
18.
TodenhoferTHennenlotterJSchmiedelBJHohnederAGrimmSKuhsUSalihHRBuhringHJFehmTGakisGBlumenstockGAufderklammSSchillingDStenzlASchwentnerC. Alterations of the rankl pathway in blood and bone marrow samples of prostate cancer patients without bone metastases. Prostate2013; 73: 162–8.
19.
SantiniDPerroneGRoatoIGodioLPantanoFGrassoDRussoAVincenziBFrattoMESabbatiniRDella PepaCPortaCDel ConteASchiavonGBerrutiATomasinoRMPapottiMPapapietroNOnetti MudaADenaroVToniniG. Expression pattern of receptor activator of nfkappab (rank) in a series of primary solid tumors and related bone metastases. J Cell Physiol2011; 226: 780–4.
20.
WittrantYTheoleyreSChipoyCPadrinesMBlanchardFHeymannDRediniF. Rankl/rank/opg: New therapeutic targets in bone tumours and associated osteolysis. Biochim Biophys Acta2004; 1704: 49–57.
21.
TinocoMLDiasBBDall'AsttaRCPamphileJAAragaoFJ. In vivo trans-specific gene silencing in fungal cells by in planta expression of a double-stranded rna. BMC Biol2010; 8: 27–27.
22.
BonjourJP. Calcium and phosphate: a duet of ions playing for bone health. J Am Coll Nutr2011; 30: 438S–48.
23.
LemsWF. Fracture risk estimation may facilitate the treatment gap in osteoporosis. Ann Rheum Dis2015; 74: 1943–5.
24.
ChmielnickaMWozniackaATorzeckaJD. The influence of corticosteroid treatment on the opg/rank/rankl pathway and osteocalcin in patients with pemphigus. Postepy Dermatol Alergol2014; 31: 281–8.
25.
KomoriT. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res2010; 339: 189–95.
26.
FanCJiaLZhengYJinCLiuYLiuHZhouY. MiR-34a Promotes osteogenic differentiation of human adipose-derived stem cells via the RBP2/NOTCH1/CYCLIN D1 coregulatory network. Stem Cell Rep2016; 7: 236–48.
27.
SaitoKNakatomiMIda-YonemochiHOhshimaH. Osteopontin is essential for type I collagen secretion in reparative dentin. J Dent Res2016; 95: 1034–41.
28.
MinennaGD'AmoreSMaggioliniPScagliusiPD'AmoreM. [RANKL/RANK, OPG and OPT in a group of patients affected by chronic arthritis. Preliminary report]. Recenti Prog Med2005; 96: 431–2.
29.
ChmielnickaMWozniackaATorzeckaJD. The influence of corticosteroid treatment on the OPG/RANK/RANKL pathway and osteocalcin in patients with pemphigus. Postepy Dermatol Alergol2014; 31: 281–8.
30.
KanazawaIYamaguchiTYamamotoMYamauchiMKuriokaSYanoSSugimotoT. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab2009; 94: 45–9.
31.
TamuraMUyamaMSugiyamaYSatoM. Canonical Wnt signaling activates miR-34 expression during osteoblastic differentiation. Mol Med Rep2013; 8: 1807–11.
